Involvement of the NLRC4 inflammasome in promoting retinal ganglion cell death in an acute glaucoma mouse model

Ke Yao,Yin Zhao,Peiming Jin,Xiaotong Lou,Zhaoxia Luo,Hong Zhang,Fei Li
DOI: https://doi.org/10.1016/j.exer.2020.108388
IF: 3.77
2021-02-01
Experimental Eye Research
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Purpose</h3><p>To explore the role of nucleotide-binding oligomerization domain-like receptors (NLRs) family caspase-activation and the recruitment domain containing 4 (NLRC4) inflammasome in retinal ganglion cell (RGC) injury induced by an acute glaucoma mouse model.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Method</h3><p>A mouse model of acute ocular hypertension, which can lead to retinal ischemia-reperfusion (I/R) injury, was established. The expression level of NLRC4 was detected by polymerase chain reaction and western blotting. Localized expression of NLRC4 was detected by examining immunofluorescence in eyeball sections. Intravitreal adeno-associated virus 2(AAV2) administration was used to knockdown retinal <em>Nlrc4</em>. Fluoro-Gold labeled RGCs and TdT-mediated dUTP nick end labeling were used to evaluate the survival and apoptosis of RGCs. <em>Tlr4</em><sup><em>−/−</em></sup> mice were utilized to explore whether NLRC4 inflammasome is influenced by Toll-like receptor4 (TLR4).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>NLRC4, expressed in RGCs and microglial cells, was actively involved in mouse retinal I/R injury. Knockdown of <em>Nlrc4</em> using an AAV2 vector caused an obvious reduction in the generation of IL-1β led by the rapidly elevated intraocular pressure, and thereby improved the RGC survival. In addition, activation of the NLRC4 inflammasome could influence the phosphorylation of p38 and Jun N-terminal kinase, which was largely dependent on TLR4 signaling.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Our study demonstrated the role of NLRC4 inflammasome in promoting RGC damage in mouse retinal I/R injury. Inhibition of NLRC4 might be leveraged as a potential therapeutic target in glaucomatous retinopathy.</p>
ophthalmology
What problem does this paper attempt to address?